Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Recruiting
18 years - 99 years
All
Phase 3
4 participants needed
1 Location

Brief description of study

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study will last for about 5 years. Participants will have up to 21 clinic visits and up to 9 phone calls with the clinical staff during the study. Some of the clinic visits may be spread over more than one day. Women cannot take part in the study if they are pregnant, breast-feeding or plan to become pregnant during the study period.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-alcoholic Steatohepatitis,NASH
  • Age: 18 years - 99 years
  • Gender: All

Male or Female, Age 18 or older, Histological evidence of NASH

This study investigates non-alcoholic steatohepatitis (NASH).

The study evaluates the effects of an investigational medication on NASH.

  • Who can participate: Adults aged 18 or older with histological evidence of NASH, both male and female, can participate.
  • Study details: Participants will inject the investigational medication under their skin once a week. An inactive substance that looks like the investigational medicine but does not contain any medicine may be used as a placebo.
  • Study timelines and visits: The study will last 5 years. The study requires 21 clinic visits.
Updated on 04 Aug 2024. Study ID: 844942

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Race
Select race of your choice
Ethnicity
Select ethinicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center